DONALD ATKINSON: Open Payments
NPI 1205938446 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 16 payments from 8 companies in 2025. Trend: 2023 $1,995 · 2024 $739 · 2025 $578
Food & beverage: $466Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Neurocrine BioSciences, Inc. | 2 | $106 |
| E.R. Squibb & Sons, L.L.C. | 2 | $77 |
| Vanda Pharmaceuticals Inc. | 1 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Alkermes, Inc. | 1 | $45 |
| Axsome Therapeutics, Inc. | 2 | $30 |
Products named: INGREZZA, COBENFY, FANAPT, CAPLYTA, LYBALVI, ABILIFY MAINTENA, ABILIFY ASIMTUFII, REXULTI.
Industry payments across TN — which companies pay providers there.
